1. Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy;
2. National Heart and Lung Institute, Imperial College London, London, United Kingdom;
3. Pulmonology and Cystic Fibrosis Unit, Internal Medicine Department, Foundation Scientific Institute for Research, Hospitalization and Healthcare Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy;
4. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy;
5. Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;
6. Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas;
7. Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, New York;
8. COPD Foundation, Washington, District of Columbia;
9. Pneumology Department, Hospital Universitari Vall d’Hebron/Vall d’Hebron Institut de Recerca, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain;
10. Sackler Institute of Pulmonary Pharmacology, King’s College London, London, United Kingdom;
11. TalSi Translational Medicine Consulting, LLC, Media, Pennsylvania; and
12. Unit of Pharmacology, Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy